Primary calcitonin-negative neuroendocrine tumor


ÖZDEN S., Colak A., Saylam B., Cengiz Ö.

World Journal of Endocrine Surgery, cilt.9, sa.3, ss.104-108, 2017 (Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 9 Sayı: 3
  • Basım Tarihi: 2017
  • Doi Numarası: 10.5005/jp-journals-10002-1221
  • Dergi Adı: World Journal of Endocrine Surgery
  • Derginin Tarandığı İndeksler: Scopus
  • Sayfa Sayıları: ss.104-108
  • Anahtar Kelimeler: Medullary thyroid cancer, Neuroendocrine tumor, Thyroid surgery
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Introduction: Neuroendocrine tumors (NETs) of the thyroid are rare tumors. Medullary thyroid carcinoma (MTC) is an exact NET of the thyroid gland, arising from the parafollicular cells (C cells). It has unique features like immunohistochemically and biochemically calcitonin positivity and amyloid deposits. In this case report, a rare thyroid tumor is presented, which has neuroendocrine staining properties and does not produce serum or cytoplasmic calcitonin. Case report: The patient was a 45-year-old woman who underwent total thyroidectomy because of the countless multiple thyroid nodules and a suspicion about a nodule at the right lobe. On histopathological examination, there was a tumor in the left thyroid lobe that measured 0.4 cm. Tumor immunohistochemical staining was positive for synaptophysin, chromogranin A (neuroendocrine cell markers), and thyroglobulin (Tg), and thyroid transcription factor-1 (TTF-1; follicular cell markers). The staining was negative for calcitonin. Conclusion: There are thyroid tumors that are calcitoninnegative and Tg-positive called calcitonin-negative NETs. Careful interpretation and distinction between MTCs are needed at these tumors because they may have different biologic behaviors, and calcitonin negativity makes follow-up of patients challenging.